Harbour Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1K | Buy |
112
+93
| +489% | +$11.7K | ﹤0.01% | 2395 |
|
|
2025
Q1 | $2.1K | Sell |
19
-2
| -10% | -$221 | ﹤0.01% | 3076 |
|
|
2024
Q4 | $2.87K | Sell |
21
-7
| -25% | -$956 | ﹤0.01% | 2910 |
|
|
2024
Q3 | $3.23K | Buy |
28
+9
| +47% | +$1.04K | ﹤0.01% | 2778 |
|
|
2024
Q2 | $2.62K | Sell |
19
-11
| -37% | -$1.52K | ﹤0.01% | 2734 |
|
|
2024
Q1 | $4.14K | Buy |
30
+4
| +15% | +$552 | ﹤0.01% | 2566 |
|
|
2023
Q4 | $3.43K | Hold |
26
| – | – | ﹤0.01% | 2539 |
|
|
2023
Q3 | $2.93K | Buy |
26
+10
| +63% | +$1.13K | ﹤0.01% | 2447 |
|
|
2023
Q2 | $1.51K | Buy |
16
+5
| +45% | +$472 | ﹤0.01% | 2618 |
|
|
2023
Q1 | $1.11K | Hold |
11
| – | – | ﹤0.01% | 2674 |
|
|
2022
Q4 | $1.31K | Buy |
11
+9
| +450% | +$1.08K | ﹤0.01% | 2628 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 2793 |
|
|
2022
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 2793 |
|
|
2021
Q4 | $0 | Sell |
2
-110
| -98% | – | ﹤0.01% | 3322 |
|
|
2021
Q3 | $11K | Buy |
112
+7
| +7% | +$688 | ﹤0.01% | 2617 |
|
|
2021
Q2 | $10K | Sell |
105
-46
| -30% | -$4.38K | ﹤0.01% | 2738 |
|
|
2021
Q1 | $15K | Buy |
+151
| New | +$15K | ﹤0.01% | 2374 |
|